SYNKRINO BIOTHERAPEUTICS

synkrino-biotherapeutics-logo

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric rheumatologists for life-threatening conditions. It is currently building a rapid, portable field test for the RNA virus 2019-nCoV/COVID-19, adapting its existing analytic protocols for community public health screening. Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.

#SimilarOrganizations #People #Financial #Website #More

SYNKRINO BIOTHERAPEUTICS

Industry:
Artificial Intelligence (AI) Biotechnology Health Care Therapeutics

Founded:
2018-01-01

Address:
Berkeley, California, United States

Country:
United States

Website Url:
http://www.synkrino.bio

Total Employee:
1+

Status:
Active

Technology used in webpage:
Amazon Google Apps For Business Cloudflare DNS AWS Global Accelerator Webflow


Similar Organizations

activeo-logo

ActiveO

ActiveO, a spine technology company, develops and delivers image-guided therapies to treat back pain.

ibis-therapeutics-logo

IBIS Therapeutics

IBIS Therapeutics is accelerating drug discovery through Molecular Fingerprintâ„¢ Platform

na-genomics-logo

N.A. Genomics

N.A. Genomics is a Personal Health AI Platform that helps to optimize health based on DNA information and other characteristics.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

transaxon-logo

TransAxon

Reality-level Brain Computer Interfaces

Current Employees Featured

not_available_image

Jason Barbour
Jason Barbour Co-Founder and CEO @ Synkrino Biotherapeutics
Co-Founder and CEO

not_available_image

David Ott
David Ott CTO and Co-Founder @ Synkrino Biotherapeutics
CTO and Co-Founder

Founder


not_available_image

David Ott

not_available_image

Jason Barbour

Investors List

endpoint-ventures_image

Endpoint Ventures

Endpoint Ventures investment in Seed Round - Synkrino Biotherapeutics

y-combinator_image

Y Combinator

Y Combinator investment in Seed Round - Synkrino Biotherapeutics

Official Site Inspections

http://www.synkrino.bio

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Synkrino Biotherapeutics"

Synkrino Biotherapeutics - PitchBook

Www.synkrino.bio. Ownership Status. Out of Business. Financing Status. Formerly VC-backed. Corporate Office. 1111 Broadway; Oakland, CA 94607; United States; Primary Industry. ... Synkrino Biotherapeutics’s primary industry …See details»

Synkrino Biotherapeutics - Y Combinator

Synkrino's AI, SATIS is a powerful, unbiased discovery system for…. Founded in by Jason Barbour and David Ott, Synkrino Biotherapeutics has 2 employees based in Oakland, CA, USA.See details»

Synkrino development company

Synkrino Development Company Synkrino Development Company Synkrino Development Company. A New Approach to Drug Development. Thousands of medical breakthroughs never make it past a lab bench. Development failures …See details»

Synkrino Biotherapeutics - VentureRadar

Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system of patients. The AI + Immunology Discovery Engine has identified two novel drug …See details»

Synkrino Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...

Last update 07 Mar 2025. Synkrino Biotherapeutics, Inc. Startups |See details»

Synkrino Biotherapeutics - Golden

Synkrino Biotherapeutics is a Berkeley, California-based biotechnology platform working on discovering and developing novel drug targets from the immune system of patients. ...See details»

Synkrino Biotherapeutics - Berkeley Emeryville BIO

Synkrino Biotherapeutics. C/O Citris Foun, UC Berkeley 450 Sutardja Dai Hall. Berkeley. Website. Developer of novel therapeutics designed to treat patients with diseases driven by the immune …See details»

Synkrino Biotherapeutics Company Profile - Office Locations ...

Synkrino Biotherapeutics has 5 employees at their 1 location. See insights on Synkrino Biotherapeutics including office locations, competitors, revenue, financials, executives, …See details»

Synkrino Biotherapeutics, Inc. - Company Profile - Corporation Wiki

Jun 14, 2018 Synkrino Biotherapeutics, Inc. Overview. Synkrino Biotherapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Thursday, June …See details»

SDC | Leadership Team - synkrino.dev

Profile: PhD, life science, med. chem, drug discovery and drug development. Professional background: GSK, LEO PharmaSee details»

Synkrino Biotherapeutics - Funding, Financials, Valuation & Investors

Aug 23, 2018 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 23, …See details»

Home - Synklino

Live life again We develop transformative therapies for the elimination of the risk for chronic viral diseases We strive to improve the quality of life of transplant recipients Transplantation is …See details»

SYNKRINO BIOTHERAPEUTICS INC Oakland CA, 94607 - Company …

Free Business profile for SYNKRINO BIOTHERAPEUTICS INC at 1111 Broadway, Oakland, CA, 94607-4139, US.See details»

Synkrino Biotherapeutics - Company Information | YCDB - The Y ...

Synkrino Biotherapeutics. Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system... Live. Statistics. Compare to all YC; Compare to S18; …See details»

David Ott - Synkrino Biotherapeutics - LinkedIn

David and I developed Synkrino Bio in early 2018, working from offices in the Berkeley School of Engineering, before joining Y Combinator that summer.See details»

Synkrino Biotherapeutics - CoBee Company Profile & Funding …

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric …See details»

Value Proposition - SDC

Synkrino Development Company partners with biotech to finance and develop innovative high impact therapeutics programs. We serve the entire pharma ecosystem of patients, prescribers, …See details»

Synkrino Biotherapeutics - Updates, News, Events, Signals & Triggers

Oct 24, 2022 Organization. Synkrino Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Research and …See details»

Synkrino Biotherapeutics - Contacts, Employees, Board Members, …

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. ... Experience the new Crunchbase, powered by …See details»

Welcome to BIO 2025: Collaboration can't wait. | BIO

2 days ago As we kick off BIO 2025, the world’s largest biotech gathering, BIO emphasizes that collaboration can’t wait. Today’s theme: Collaboration—between government and industry, …See details»

linkstock.net © 2022. All rights reserved